EROAD (ERD)•FY26•Released 25 May 2026$161m loss on North America impairment as EBITDA fell 35%The headline loss is non-cash but underlying EBITDA fell from $59.6m to $39.0m and free cash flow dropped to $0.1m as capex nearly doubled.Published 25 May 2026Read briefing→
EROAD (ERD)•HY26•Released 21 November 2025EROAD posts $144.2m H1 loss on charge below EBITDA as cash flow liftsRevenue grew 3.3% and free cash flow rose to $5.1m, but a non-cash charge well below EBITDA drove a $144.2m loss and cut equity by roughly $125m.Published 21 April 2026Read briefing→
EROAD (ERD)•FY25•Released 26 May 2025FCF rose to $16.0m but operating cash conversion fell to 72.5%Capex fell 58.4% as the 4G program rolled off, but OCF/EBITDA dropped from 99.2% to 72.5% even as EBITDA grew to $59.6m.Published 22 April 2026Read briefing→
EROAD (ERD)•FY24•Released 23 May 2024FCF turned positive and net debt fell $40.4m, but PBT loss widened 37.3%Operating cash flow more than doubled to $52.9m and leverage halved, yet the loss before tax deepened despite EBITDA expanding to $53.3m.Published 22 April 2026Read briefing→
EROAD (ERD)•HY24•Released 29 November 2023Normalised revenue up 13%, EBITDA up 23.8% as net debt/EBITDA falls to 1.4xReported revenue growth of 4.7% understates the underlying 13% pace because HY23 carried a $7.0m one-off Coretex acquisition accounting credit.Published 22 April 2026Read briefing→
EROAD (ERD)•FY23•Released 24 May 2023Coretex full-year lift drove 52% revenue growth as net debt jumped to $62.5mFY23 hit guidance but cash conversion fell to 53.3% and receivable days nearly doubled to 47.0 while net debt rose from $18.2m.Published 22 April 2026Read briefing→